Measuring confidence after stroke
This study will explore what ‘confidence’ means to people who have had a stroke, the perceived barriers, and what helps stroke survivors to regain confidence.
Does fluoxetine improve recovery after stroke? Start-up phase for a large trial
Does fluoxetine improve recovery after stroke? Start-up phase for a large trial.
Visual scanning training interventions help people with visual field loss after stroke?
Junior Research Training Fellowship: Christine Hazelton
Understanding the difficulty in controlling emotions after stroke
Understanding the difficulty in controlling emotions after stroke
An initial evaluation of a new therapy programme which aims to improve arm function after stroke
This project aims to develop and test a repetitive functional task practice (RFTP) therapy programme. Research physiotherapists will develop the programme in conjunction with stroke unit staff and patients.
How do other illnesses affect stroke treatment and outcomes? A study using national datasets
This study will investigate how other illnesses can affect stroke treatment and outcome. It will involve the analysis of electronic, linked datasets of health information from stroke patients in Scotland.
Understanding and treating biological changes after a bleed in the brain
Intracerebral haemorrhage (ICH) is a type of stroke, which is caused by bleeding in the brain, ultimately leading to brain damage, disability and often death. We currently know very little about the biological changes that occur in the brain after intracerebral haemorrhage.
Jon Barrick, President of SAFE, awarded honorary doctorate
Wednesday 5 July 2017
President of the Stroke Alliance for Europe (SAFE) awarded Professional Doctorate in Policy Research and Practice honoris causa from University of Bath
Brain bleeds in patients on medication for atrial fibrillation - new study
Wednesday 19 April 2017
Published online first in the journal Neurology, a new study suggests that people with AF who have an ICH due to their medication have similar outcomes whether they're on a NOAC or a vitamin K antagonist drug.
Research highlights from UK Stroke Forum 2017
The UK Stroke Forum 2017 took place this week at the ACC in Liverpool.